in spring 2022, FDA approved Mounjaro (tirzepatide) for use in the United States to treat type 2 diabetes.
In November 2023, FDA approved a new version of Mounjaro, called Zepbound, for use as a weight loss drug.
------------
What company makes Mounjaro (tirzepatide), Zepbound?
Lilly is the only lawful supplier of FDA-approved tirzepatide medicines—Mounjaro ® and Zepbound ® and does not provide tirzepatide (active ingredient in Mounjaro ® and Zepbound ®) to compounding pharmacies, med-spas, wellness centers, online retailers, or other manufacturers. Jun 20, 2024
Novo Nordisk’s Ozempic, Wegovy and Eli Lilly’s Mounjaro and Zepbound,
^^What are the ingredients in tirzepatide?
Active ingredient: tirzepatide Inactive ingredients: sodium chloride, sodium phosphate dibasic heptahydrate, and water for injection. Hydrochloric acid solution and/or sodium hydroxide solution may have been added to adjust the pH
-------------
Tirzepatide (active ingredient in Mounjaro ® and Zepbound ®)
-Anorexia(신경성 식욕 부진증, 거식증), -Hunger, -(1% to 10%): hyperglycemia, -Belching,
MOUNJARO has been associated with gastrointestinal adverse reactions, which include nausea, vomiting, and diarrhea [see Adverse Reactions (6.1)]. These events may lead to dehydration, which if severe could cause acute kidney injury.
Does Zepbound cause kidney issues?
Zepbound can cause serious side effects, including: Kidney problems (kidney failure).
Diarrhea, nausea, and vomiting may cause a loss of fluids (dehydration), which may cause kidney problems.
Common side effects of Mounjaro (tirzepatide) include nausea, vomiting, and fatigue.
In some severe cases, Mounjaro may also cause stomach paralysis.
The most common side effects of Zepbound include abdominal pain, burping, nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, dyspepsia, fatigue, injection site reactions, gastroesophageal reflux disease, feeling tired, allergic reactions, belching, hair loss, and heartburn. hypersensitivity reactions, injection site reactions,
------
;Zepbound and Mounjaro(tirzepatide) price;
Mounjaro (tirzepatide) is typically priced between $1,020 to $1,200 per month before insurance,
while the out-of-pocket cost for Zepbound is listed at $1,060 per month.
------
Are Zepbound and Mounjaro(tirzepatide) the same?
Zepbound and Mounjaro share the same active ingredient, tirzepatide.
The main difference between Zepbound vs. Mounjaro is that they are FDA-approved to treat different health conditions.
Zepbound is indicated for weight loss, while
Mounjaro(tirzepatide) is indicated for type 2 diabetes. May 6, 2024,